{"prompt": "['056-F275, Clinical Investigation Plan Template, Version 2.0', 'Page 59 of 115', 'MEC/IRB', 'All geographies: Submit to MEC/IRB per local reporting requirement.', 'Regulatory', 'All geographies: Submit as soon as possible after the Investigator first learns of the', 'authorities', 'event, and per local requirements', 'HOMI', 'Japan: The Principal Investigator shall immediately report to HOMI. (MHLW Ordinance', '36, 2005 Article 68)', 'Sponsor submit to:', 'Investigator', 'Japan: All SADEs classified as reportable events follow the applicable reporting', 'requirements. (MHLW Ordinance 36, 2005 Article 28)', 'MEC/IRB', 'All geographies: Submit to MEC/IRB per local reporting requirement.', 'Japan: in the case where there is a prior agreement with the IRB and HOMI, all SADEs', 'classified as reportable events follow the applicable reporting requirements. (MHLW', 'Ordinance 36, 2005 Article 28)', 'Regulatory', 'Canada: All SADEs on the patient, the user or any other person: these must be', 'authorities', 'reported by Medtronic to the regulatory within 10 days from the date the first person', 'becomes aware. Preliminary and final reporting to the Canadian Ministry of Health', '(Health Canada) of events occurring inside (always) or outside Canada (in case of', 'corrective actions) that is related to a failure of the device or a deterioration in its', 'effectiveness, or any inadequacy in its labeling or its directions for use and has led to', 'the death or a serious deterioration in the state of health of a patient, user or other', 'person or could do so were it to recur. Report a) within 10 days after awareness, if', 'incident has led to death or a serious deterioration in the state of health of a patient,', 'user or other person b) within 30 days, if incident has not led to death or a serious', 'deterioration in the state of health of a patient, user or other person, but could do so', 'were it to recur c) as soon as possible, if incident occurred outside of Canada and', 'is', 'related to a corrective action. (Medical Devices Regulation Mandatory Problem', 'Reporting 59(1), 59(2), 60 (1))', 'Japan: All SADEs classified as reportable events follow the applicable reporting', 'requirements. (Pharmaceutical Affairs Law Enforcement Regulations, Article 273, 275)', 'All geographies: Submit to regulatory authority per local reporting requirement.', 'HOMI', 'Japan: All SAEs classified as reportable events follow the applicable reporting', 'requirements. (MHLW Ordinance 36, 2005 Article 28)', 'Unanticipated Adverse Device Effects (UADEs) and Unanticipated Serious Adverse Device Effects', '(USADEs)', 'Investigator submit to:', 'Medtronic', 'US: Submit as soon as possible, but no later than within 10 working days after the', 'Investigator first learns of the event. (21 CFR 812.150(a)(1))', 'Europe: Immediately after the Investigator first learns of the event or of new', 'Version 4, 10NOVO016', 'Confidential']['056-F275, Clinical Investigation Plan Template, Version 2.0', 'Page 60 of 115', 'information in relation with an already reported event.', 'Japan: The Principal Investigator shall immediately report to the sponsor. (MHLW', 'Ordinance 36, 2005 Article 68)', 'MEC/IRB', 'US: Submit as soon as possible, but no later than within 10 working days after the', 'Investigator first learns of the event. (21 CFR 812.150(a)(1))', 'All geographies: Submit to MEC/IRB per local reporting requirement.', 'Regulatory', 'Europe: Submit to regulatory authority per local reporting requirement.', 'authorities', 'HOMI', 'Japan: The Principal Investigator shall immediately report to HOMI. (MHLW Ordinance', '36, 2005 Article 68)', 'Sponsor submit to', 'Investigator', 'All geographies: Notification as soon as possible and not later than 10 working days', 'after the sponsor first learns of the effect. (21 CFR 812.150(b)(1))', 'Japan: Report to the Principal Investigator per reporting requirements (MHLW', 'Ordinance 36, 2005 Article 28)', 'MEC/IRB', 'All geographies: Notification as soon as possible and not later than 10 working days', 'after the sponsor first learns of the effect. (21 CFR 812.150(b)(1))', 'Japan: Report to the IRB per reporting requirements in the case where there is a prior', 'agreement with the IRB and HOMI. (MHLW Ordinance 36, 2005 Article 28)', 'Regulatory', 'US: Notification as soon as possible to FDA, but not later than 10 working days after', 'authorities', 'the sponsor first learns of the effect. (21 CFR 812.150(b)(1))', 'Canada: All USADEs on the patient, the user or any other person; these must be', 'reported by Medtronic to the regulatory within 10 days from the first person', 'at', 'Medtronic that becomes aware. Preliminary and final reporting to the Canadian', 'Ministry of Health (Health Canada) of events occurring inside (always) or outside', 'Canada (in case of corrective actions) that is related to a failure of the device or a', 'deterioration in its effectiveness, or any inadequacy in its labeling or its directions for', 'use and has led to the death or a serious deterioration in the state of health of a', 'patient, user or other person or could do so were it to recur. Report a) within 10 days', 'after awareness, if incident has led to death or a serious deterioration in the state of', 'health of a patient, user or other person b) within 30 days, if incident has not led to', 'death or a serious deterioration in the state of health of a patient, user or other person,', 'but could do so were it to recur c) as soon as possible, if incident occurred outside of', 'Canada and is related to a corrective action. (Canada Medical Device Regulations,', 'SOR/98-282; Mandatory Problem Reporting 59(1), 59(2), 60 (1))', 'Europe: Submit to regulatory authorities per local reporting requirement.', 'Japan: Report to the regulatory authorities per reporting requirements.', '(Pharmaceutical Affairs Law Enforcement Regulations, Article 273, 275)', 'Version 4, 10NOVO016', 'Confidential']\n\n###\n\n", "completion": "END"}